Advertisement


Patricia A. Ganz, MD, on Looking Beyond the Scans: What to Look For and How

2016 Cancer Survivorship Symposium

Advertisement

Patricia A. Ganz, MD, of the University of California at Los Angeles, discusses the limited sensitivity and specificity of surveillance testing for cancer recurrence and finding a better way to reassure patients about their continuing care.



Related Videos

Survivorship
Breast Cancer

Jennifer A. Ligibel, MD, on Breast Cancer Survivorship in Young Women

Jennifer A. Ligibel, MD, of the Dana-Farber Cancer Institute, discusses the physical activity behaviors and weight changes in a study cohort of young women with breast cancer (Abstract 166).

Survivorship

Mary S. McCabe, RN, on Risk-Based Health Care of Cancer Survivors

Mary McCabe, RN, of Memorial Sloan Kettering Cancer Center, discusses various models of delivering survivorship care.

Survivorship

Kerri M. Winters-Stone, PhD, on Peripheral Neuropathy: High Prevalence Among Female Survivors

Kerri M. Winters-Stone, PhD, of Oregon Health and Science University, discusses the results of her study, which showed that, years after treatment, nearly half of women cancer survivors still have symptoms of chemotherapy-induced peripheral neuropathy. The findings may inform rehabilitative programs to prevent falls and injuries (Abstract 130).

Survivorship

Christopher J. Recklitis, PhD, MPH, on Fatigue and Sleep Disturbances

Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, discusses these side effects and some practical approaches to managing them with educational, medical, behavioral, and lifestyle interventions.

Survivorship

Tim A. Ahles, PhD, on Neurocognitive Late Effects

Tim A. Ahles, PhD, of Memorial Sloan Kettering Cancer Center, discusses “chemobrain” and what can be done to help patients cope with this symptom.

Advertisement

Advertisement



Advertisement